TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/23/2026
Back to search
Official data from USPTO
COMBINAGE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
COMBINAGE
ST13
US500000079377556Class
9, 42, 44
Filing
79377556
Registration
7717676
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
04/25/2026
Trademark type
Word
Nice classes
9, 42, 44
Filing date
07/25/2023
Registration date
03/11/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/11/2025
Last transaction
04/25/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
32
Owner location
B-3590 Diepenbeek, BE
Examiner
BROWN, TINA
Law office
M90
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Rejuvenate Biomed NV
Rejuvenate Biomed NV
Representatives
Cheryl L. Burbach Erise IP, P.A.
Technical classification
Nice Classes
Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable artificial intelligence software for data analysis for use in the life sciences research fieldpharmaceutical researchmedical researchdrug discovery and development; downloadable artificial intelligence software for healthcare for capturingstoringprocessingevaluating and reproducing medical and pharmaceutical data; downloadable artificial intelligence software for data analysis; downloadable software using artificial intelligence for machine learning for healthcare; downloadable health monitoring software for data analysis; downloadable software relating to the medical field for controlling and managing patient medical information; downloadable software for data analysis relating to the pharmaceutical field for drug discovery and development; downloadable bioinformatics software for drug discovery and developmentfor controlling and managing patient medical information; electronic databasesdownloadable databases and electronic database recorded on computer mediafor capturingstoringprocessingevaluating and reproducing medical and pharmaceutical data
Class 42
Providing temporary use of non-downloadable artificial intelligence computer programs on data networks for data analysis for use in the life sciences research fieldpharmaceutical researchmedical researchdrug discovery and development; platforms for artificial intelligence as software as a service (SaaS)platform as a service (PAAS) featuring computer software platforms using artificial intelligence for data analysis for use in the life sciences research fieldpharmaceutical researchmedical researchdrug discovery and development; software as a service (SaaS) services featuring computer software platforms for data analysis for artificial intelligence for use in the life sciences research fieldpharmaceutical researchmedical researchdrug discovery and development; software as a service (SaaS) services featuring software for data analysis for use in the life sciences research fieldpharmaceutical researchmedical researchdrug discovery and development; software as a service (SaaS) services featuring artificial intelligence software for data analysis for use in the life sciences research fieldpharmaceutical researchmedical researchdrug discovery and development; software as a service (SaaS) services featuring artificial intelligence software for healthcare for capturingstoringprocessingevaluating and reproducing medical and pharmaceutical data; software as a service (SaaS) services featuring artificial intelligence software for data analysis; software as a service (SaaS) services featuring software using artificial intelligence for machine learning for healthcare; software as a service (SaaS) services featuring health monitoring software for monitoring health data; software as a service (SaaS) services featuring software relating to the medical field for controlling and managing patient medical information; software as a service (SaaS) services featuring bioinformatics software for drug discovery and developmentfor controlling and managing patient medical information; providing temporary use of non-downloadable software for capturingstoringprocessingevaluating and reproducing medical and pharmaceutical data; computer programming in the medical field; scientific computer programming services; artificial intelligence technology consultancy; research in the field of artificial intelligence; pharmaceutical research services; pharmaceutical products development; pharmaceutical product evaluation; research of pharmaceuticals; testing of pharmaceuticals; research relating to pharmaceuticals; development of gene-based medicines; conducting clinical trials for others for pharmaceutical products; laboratory research services relating to pharmaceuticals; consultancy in the field of pharmaceutical research; services for assessing the efficiency of pharmaceuticalstesting of pharmaceuticalspharmaceutical research and development; information technology services for the pharmaceutical and healthcare industriesnamely information technology consultancy relating to installationmaintenance and repair of computer software; conducting early evaluations in the field of new pharmaceuticalstesting of pharmaceuticals; providing information about pharmaceutical researchthe results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; chemical research and analysis services; medical and pharmacological research services; scientific research for medical purposes; drug discovery services; medical and scientific researchconducting clinical trials for others; genetic researchproviding scientific research information in the field of geneticsproviding medical research information in the field of genetics; genetic mapping for scientific purposes; providing scientific information in the field of medical disorders and their treatment
Class 44
Pharmaceutical servicespharmaceutical compoundingpharmaceutical advice; pharmaceutical consultation; pharmaceutical advisory services; provision of pharmaceutical informationproviding information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals; medical services; medical consultancy services; medical advisory services; medical evaluation servicesmedical testing for fitness evaluationmedical evaluation of cancermetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and conditionsconducting medical physical evaluations; medical diagnostic services; medical examination services; services for the provision of medical care informationproviding medical care informationproviding medical care information via a website; medical services for the diagnosis of conditions of the human body; medical services for the treatment of conditions of the human body; medical care and analysis services relating to patient treatment; medical screening; drug screening for medical purposes; genetic testing for medical purposes
Publications
History of USPTO decisions and trademark events.
41 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/23/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/23/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/23/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/23/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/14/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/10/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/22/2025
FIMP
FINAL DISPOSITION PROCESSED
09/22/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/11/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/28/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/11/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
03/11/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/15/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/27/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/26/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
12/19/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/08/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/17/2024
PUBO
PUBLISHED FOR OPPOSITION
09/17/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/28/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/13/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
08/13/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/13/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
08/13/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/13/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/29/2024
GNFR
FINAL REFUSAL E-MAILED
06/29/2024
CNFR
FINAL REFUSAL WRITTEN
06/29/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/24/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/24/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/24/2024
RFNT
REFUSAL PROCESSED BY IB
05/08/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/17/2024
RFRR
REFUSAL PROCESSED BY MPU
04/17/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/29/2024
CNRT
NON-FINAL ACTION WRITTEN
03/28/2024
DOCK
ASSIGNED TO EXAMINER
03/27/2024
MAFR
APPLICATION FILING RECEIPT MAILED
09/12/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/07/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/31/2023
Continuous trademark protection
Get notified about every new filing that threatens COMBINAGE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.